ALT icon

Altimmune (ALT)

NASDAQ

$3.12

$0.0050 (

+0.16%

)

1D
5D
1M
6M
1Y
5Y
Market closed

ALT: $3.12 / ₿ 0 BTC / 4680 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$3.12
$2.87 - $7.73
$405.93M
1.73
$1.00
130.11M
$3.12 - $3.18
Yes

What is Altimmune (ALT)?

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

The Altimmune (ALT) stock price has been rising

The Altimmune, Inc. Common Stock (ALT) stock price today is $3.12, reflecting a +0.16% move since the market opened. The company’s market capitalization stands at $405.93M, with a daily trading volume of $1.00 shares. The previous closing price was $3.12.

Get started with Altimmune (ALT)

Ready to get started? Follow the steps below, or read our guide on how to buy Altimmune stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ALT

Search for ALT in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ALT.

ALT FAQs

ALT is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ALT is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Altimmune, Inc. Common Stock (ALT) has traded between a low of $2.87 and a high of $7.73.

ALT is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Altimmune? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ALT icon
ALT

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Altimmune in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

RBOTW icon

Top losers

Compare the worst-performing stocks of 
the day

SDCCQ icon
YOTAR icon

YOTAR

BBIG icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.